302 Hospital

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• HIV1 trial
• Liver and biliary tract cancer1 trial

Phase

• Phase 22 trials

Status

• Recruiting2 trials

Lead sponsor

• Beijing 302 Hospital1 trial
• Beijing Gene Key Life Technology Co., Ltd1 trial

Running trials

• Recruiting

  Targeted Therapies for Immunological Non-Responders in People With HIV: A Multicenter Clinical Study

  NCT07637877· Phase 2· Beijing 302 Hospital· Source

  Contact: Fu-Sheng Wang, MD

• Recruiting

  GKL-006 Injection Plus TACE Versus TACE Alone in Patients With Unresectable Hepatocellular Carcinoma

  NCT07209813· Phase 2· Beijing Gene Key Life Technology Co., Ltd· Source

  Contact: Hepatobiliary Surgery, Department of Hepatology

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• HIV1 recruiting
• Liver and biliary tract cancer1 recruiting